Regulatory challenges of launching a biosimilar in Europe
Commercial challenges of launching biosimilars in Europe
Current EMEA guidelines
Successfully launched biosimilars in the UK to date
How this will impact regulatory approval
Recent changes to these guidelines
CURRENT STATE OF REGULATORY PROCESSES IN THE US
Successful and unsuccessful applications
THE FUTURE LANDSCAPE OF BIOSIMILARS
COMMERCIALISING BIOSIMILARS AND PATENT/ IP ISSUES
Past Events
Biosimilars - Commercial Strategies and Regulatory Guidelines 2013 - 09 Dec 2013, Holiday Inn London Bloomsbury, United Kingdom (40577)
Biosimilars - Commercial Strategies and Regulatory Guidelines 2026
Important
Please, check "Biosimilars - Commercial Strategies and Regulatory Guidelines" official website for possible changes, before making any traveling arrangements
